Syncom Formulations (India) Share Price
Know More₹15.11-0.27 (-1.76%)
5-Dec-2025₹15.14-0.17 (-1.11%)
5-Dec-2025BSE : 524470
NSE : SYNCOMF
Sector : Health care
ISIN Code : INE312C01025
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 05-Dec-2025
| Market Cap (₹ Cr) | 1,420 |
Traded Value (₹ Cr) | 0.17 |
Volume (Shares) | 1,12,765 |
Face Value (₹) | 1 |
52-Week High (₹) | 23.95 |
52-Week High Date | 10-Dec-2024 |
52-Week Low (₹) | 14.10 |
52-Week Low Date | 03-Mar-2025 |
All Time High (₹) | 27.94 |
All Time High Date | 10-Sep-2024 |
All Time Low (₹) | 0.14 |
All Time Low Date | 15-Jan-1998 |
Syncom Formulations (India) Ltd
Market News
Syncom Formul. Announcement
Syncom Formulations (India) Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 1,423 |
| EPS - TTM (₹) [C] | 0.67 |
| P/E Ratio (X) [C] | 22.60 |
| Face Value (₹) | 1 |
| Latest Dividend (%) | 3.00 |
| Latest Dividend Date | 09-Sep-2022 |
| Dividend Yield (%) | - |
| Book Value Share (₹) [C] | 4.03 |
| P/B Ratio (₹) [C] | 3.76 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | 0.02 | 11,982 | 0.06 |
| Bandhan BSE Healthcare Index Fund - Regular (G) | 0.01 | 6,247 | 0.06 |
| Bandhan BSE Healthcare Index Fund - Direct (G) | 0.01 | 6,247 | 0.06 |
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 15.05 15.37 |
| Week Low/High (₹) | 15.05 16.00 |
| Month Low/High (₹) | 15.05 17.00 |
| Year Low/High (₹) | 14.10 24.00 |
| All time Low/High (₹) | 0.14 28.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -3.20% | 10.24% | 0.01% | -0.06% |
| 1 Month | -7.29% | 5.19% | 2.70% | 2.30% |
| 3 Month | -11.77% | 0.12% | 6.20% | 5.84% |
| 6 Month | -28.52% | -18.73% | 5.24% | 5.80% |
| 1 Year | -32.02% | -22.60% | 4.83% | 5.98% |
| 3 Year | 90.20% | 116.73% | 36.41% | 40.03% |
Company Info
Company Information
Chairman & Exec. Director : Kedarmal Bankda
ED / MD / Promoter : Vijay Bankda
Independent Non Exe. Director : Ruchi Jindal
Independent Non Exe. Director : Ritesh Kumar Lunkad
Independent Non Exe. Director : Ankit Jain
Chairman / Executive Director / WTD : ANKIT KEDARMAL BANKDA
Company Sec. & Compli. Officer : Vaishali Agrawal
Registered Office: 7 Niraj Indl Estate Andheri(E), Off Mahakali Caves Rd,Mumbai,Maharashtra-400093 Ph: 91-22-30887744
FAQs about Syncom Formulations (India) Ltd
1. What's the Syncom Formulations (India) Ltd share price today?
Syncom Formulations (India) Ltd share price was Rs 15.11 at close on 5th Dec 2025. Syncom Formulations (India) Ltd share price was down by 1.76% from the previous closing price of Rs 15.38. Syncom Formulations (India) Ltd share price trend:
- Last 1 Month: Syncom Formulations (India) Ltd share price moved down by 7.29% on BSE.
- Last 3 Months: Syncom Formulations (India) Ltd share price moved down by 11.77% on BSE.
- Last 12 Months: Syncom Formulations (India) Ltd share price moved down by 32.02% on BSE.
- Last 3 Years: Syncom Formulations (India) Ltd share price moved up by 90.20% on BSE.
2. How can I quickly analyse the performance of the Syncom Formulations (India) Ltd stock?
The performance of the Syncom Formulations (India) Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 22.60
- Price to book value ratio is 3.76
- The EPS (trailing 12 months) of the Syncom Formulations (India) Ltd stock is Rs 0.67
3. What is the market cap of Syncom Formulations (India) Ltd?
Syncom Formulations (India) Ltd has a market capitalisation of Rs 1,420 crore.
4. What is Syncom Formulations (India) Ltd's 52-week high/low share price?
The Syncom Formulations (India) Ltd’s 52-week high share price is Rs 23.95 and 52-week low share price is Rs 14.10.
5. Is the Syncom Formulations (India) Ltd profitable?
On a consolidated basis, Syncom Formulations (India) Ltd reported a profit of Rs 16.60 crore on a total income of Rs 126.97 crore for the quarter ended 2025.
6. Which are Syncom Formulations (India) Ltd’s peers in the Health care sector?
Syncom Formulations (India) Ltd’s top 5 peers in the Health care sector are Shukra Pharma., Windlas Biotech, Megasoft, Syncom Formul., Hester Bios, Jagsonpal Pharma, Sigachi Indust..
7. Who owns how much in Syncom Formulations (India) Ltd?
Key changes to the Syncom Formulations (India) Ltd shareholding are as follows:
- Promoter holding in Syncom Formulations (India) Ltd has gone up to 50.57 per cent as of Sep 2025 from 50.57 per cent as of Dec 2024.
